Streetbeat News

Stock Prices

RARE

Ultragenyx Pharmaceutical (NASDAQ:RARE) received mixed analyst ratings, with a majority being somewhat bullish. Analysts set a 12-month average price target of $89.7, slightly up from the previous $88.30. The company's financials show strong revenue growth but challenges in profitability and returns.

Portfolio Pulse from Benzinga Insights

September 20, 2024 | 6:00 pm

GME

GameStop shares are experiencing an upward trend, potentially benefiting from an index rebalance occurring tonight. The stock has been a focal point for retail investors.

Portfolio Pulse from Benzinga Newsdesk

September 20, 2024 | 5:55 pm

BNGE

DIS

GK

Walt Disney Company has appointed Jared Bush as Chief Creative Officer of Walt Disney Animation Studios, while Jennifer Lee steps back to focus on the Frozen franchise. The Frozen series is crucial for Disney, having grossed billions globally. Disney's stock has gained over 13% in the past year.

Portfolio Pulse from Nabaparna Bhattacharya

September 20, 2024 | 5:51 pm

ARKB

ETHA

FBTC

Bitcoin is projected to reach $65,000 due to increased long positions and bullish options activity. Despite a slight dip, Bitcoin and Ethereum are seeing significant ETF inflows, with Ark Invest & 21Shares' ETF and Fidelity's ETF leading for Bitcoin, and BlackRock's ETF for Ethereum.

Portfolio Pulse from Murtuza Merchant

September 20, 2024 | 5:51 pm

CVX

Chevron has seen unusual options activity with a bearish sentiment, as 62% of trades were bearish. The options activity suggests a targeted price range of $80 to $155. Despite this, analysts maintain a positive outlook with a price target of $189.

Portfolio Pulse from Benzinga Insights

September 20, 2024 | 5:47 pm

RBLX

Roblox (NYSE:RBLX) has seen a surge in options activity with equal bullish and bearish trades. The focus is on a price range of $40-$50. Current trading volume is high, but the stock is down 1.25% at $45.72. Analysts have set a price target of $51, with BTIG maintaining a Buy rating.

Portfolio Pulse from Benzinga Insights

September 20, 2024 | 5:47 pm

SAVA

Cassava Sciences shares are under scrutiny as Adam Feuerstein tweets about Matt Nachtrab, a retail investor who previously bought $70M of SAVA, starting to sell his stake.

Portfolio Pulse from Benzinga Newsdesk

September 20, 2024 | 5:41 pm

PPBT

HC Wainwright & Co. has maintained a Buy rating on Purple Biotech (NASDAQ:PPBT) and adjusted its price target to $33 following a 1-20 reverse stock split.

Portfolio Pulse from Benzinga Newsdesk

September 20, 2024 | 5:38 pm

ASTS

CHTR

DIS

GOOG

META

NFLX

RDDT

TMUS

TTWO

The article highlights unusual options activity in the Communication Services sector, focusing on large transactions by 'whales' in stocks like META, GOOG, ASTS, TMUS, CHTR, RDDT, TTWO, DIS, and NFLX. These activities can indicate potential trading opportunities.

Portfolio Pulse from Benzinga Insights

September 20, 2024 | 5:35 pm

AFRM

C

COIN

FHN

JPM

NU

PRU

PYPL

SOFI

SQ

The article highlights unusual options activity for several financial stocks, indicating potential trading opportunities. Notable mentions include bearish sentiment for NU, C, FHN, AFRM, SOFI, COIN, PYPL, and JPM, while SQ and PRU show bullish sentiment.

Portfolio Pulse from Benzinga Insights

September 20, 2024 | 5:35 pm